Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Diabetes Mellitus

fingolimod hydrochloride has been researched along with Diabetes Mellitus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Asahi, M; Culp, C; Foos, WF; Patronas, M1
Bluestone, JA; Penaranda, C; Ruddle, NH; Tang, Q1
Aronovich, A; Bachar-Lustig, E; Bitcover, R; Cohen, S; Eventov-Friedman, S; Feine, I; Katchman, H; Reisner, Y; Rosen, C; Shezen, E; Tal, O; Tchorsh-Yutsis, D; Zangi, L; Zlotnikov Klionsky, Y1
Bueno, V; Burdmann, EA; Franco, M; Gallo, AP; Silva, LB1
Brinkmann, V; Deleo, J; Fu, F; Hoover, J; Hopf, C; Hu, S; Lake, P; Li, S; Shi, VC; Wang, S1

Other Studies

5 other study(ies) available for fingolimod hydrochloride and Diabetes Mellitus

ArticleYear
Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema.
    BMJ case reports, 2022, Nov-11, Volume: 15, Issue:11

    Topics: Diabetes Mellitus; Diabetic Retinopathy; Fingolimod Hydrochloride; Fluoresceins; Humans; Macular Edema; Visual Acuity

2022
Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
    Diabetes, 2010, Volume: 59, Issue:6

    Topics: Adolescent; Animals; CD4-Positive T-Lymphocytes; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; DNA-Binding Proteins; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Islets of Langerhans; Lymphocytes; Mice; Mice, Inbred NOD; Mice, Knockout; Propylene Glycols; Sphingosine; T-Lymphocytes; Young Adult

2010
Embryonic pig pancreatic tissue for the treatment of diabetes: potential role of immune suppression with "off-the-shelf" third-party regulatory T cells.
    Transplantation, 2011, Feb-27, Volume: 91, Issue:4

    Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus; Embryo, Mammalian; Fingolimod Hydrochloride; Graft Survival; Immunosuppressive Agents; Insulin; Mice; Mice, Inbred C57BL; Pancreas Transplantation; Propylene Glycols; Sirolimus; Sphingosine; Swine; T-Lymphocytes, Regulatory; Transplantation Tolerance; Transplantation, Heterologous

2011
Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
    International immunopharmacology, 2006, Dec-20, Volume: 6, Issue:13-14

    Topics: Animals; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus; Diuresis; Drug Synergism; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Lymphocyte Count; Lymphopenia; Male; Mice; Mice, Inbred C57BL; Potassium; Propylene Glycols; Sodium; Sphingosine; Tacrolimus

2006
Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
    Transplantation, 2002, May-15, Volume: 73, Issue:9

    Topics: Animals; Autoimmune Diseases; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fingolimod Hydrochloride; Graft Survival; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred NOD; Propylene Glycols; Sphingosine; Time Factors

2002